Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors: a nationwide population-based study using the French national health data system.

Laëtitia PensoChristina BergqvistAntoine MeyerPhilippe HerlemontAlain WeillMahmoud ZureikRosemary Dray-SpiraEmilie Sbidian

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)

Compared with patients initiating etanercept that displayed the same severity of the underlying disease, IL17i new-users did not present a higher risk of IBD. These results need to be confirmed in other large databases.

Keyphrases

ankylosing spondylitis
rheumatoid arthritis
end stage renal disease
disease activity
newly diagnosed
chronic kidney disease
ejection fraction
big data
prognostic factors
peritoneal dialysis
electronic health record
juvenile idiopathic arthritis
machine learning
artificial intelligence
data analysis